Australia’s medicinal cannabis industry converges at Crown Promenade Melbourne for ACannabis 2026, the nation’s premier regulatory and commercial gathering. Now entering its 7th year, ACannabis offers licensed operators direct access to TGA, ODC, and AHPRA representatives shaping the future of cannabis compliance in Australia.
With over 923,000 prescriptions issued in 2024 and domestic production growing 55% to 41,328 kg, Australia’s medicinal cannabis market has matured beyond startup mode. The conversations now focus on operational excellence, export readiness, and sustainable compliance systems.
Australian medical cannabis exports grew from 99 kg in 2021 to over 2 tonnes in 2024, with the domestic market valued between AUD $445-700 million.
Whether you’re seeking clarity on TGO 93 requirements, evaluating seed-to-sale technology for ODC compliance, or exploring EU-GMP certification pathways for export markets, ACannabis brings together the decision-makers shaping Australia’s cannabis industry under one roof.
ACannabis attracts a focused community of professionals navigating Australia’s dual-licensing regulatory framework. The event provides unmatched networking with the regulators who directly oversee cultivation, manufacturing, and prescribing activities.
The 2025 edition of ACannabis marked several significant developments that will shape discussions at the 2026 event. AHPRA’s July 2025 prescribing guidance addressed concerns about practitioners issuing over 10,000 scripts in six-month periods, signaling increased scrutiny on prescriber practices.
The Department of Agriculture made its first appearance at ACannabis in 2025, reflecting growing importance of import/export biosecurity requirements as Australian producers expand into international markets. With exports to the UK growing from 99 kg (2021) to over 2 tonnes (2024), biosecurity and trade documentation have become critical considerations.
Australia’s medicinal cannabis market reached 923,356 prescriptions in 2024, with domestic production growing 55% to 41,328 kg as operators scale for export.
TGA Access Data & Hemp Gazette, 2024Whether you’re attending for the first time or returning to expand your network, these practical tips will help you maximize your conference experience.
Australia operates one of the world’s most rigorous medicinal cannabis regulatory frameworks. The dual-licensing structure means operators must satisfy two distinct compliance regimes simultaneously – neither licence substitutes for the other.
Related: Understanding TGA & ODC Requirements for Australian Cannabis OperationsACannabis has established itself as the preferred venue for regulators to communicate directly with industry. Understanding why and how these agencies participate helps attendees maximize the event’s value.
The Department of Agriculture made its first appearance at ACannabis in 2025, reflecting the increasing importance of import/export compliance as Australian producers pursue international markets. With exports to the UK growing from 99 kg (2021) to over 2 tonnes (2024), biosecurity and trade documentation requirements have become critical.
Prepare specific questions for regulator sessions – generic inquiries waste limited access time. Bring documentation of compliance challenges for informal consultation opportunities. Attend Advisory Day for intensive regulatory workshops (sells out early). Network with other operators facing similar regulatory scenarios and document regulator responses for internal compliance teams.
Disclaimer: Regulator attendance at industry events provides general guidance. Formal licensing decisions require official applications through established channels.
Cannabis businesses operating in Australia’s dual-licensing framework encounter operational complexities that require significant planning and system adaptation. Conference attendees frequently discuss these common challenges:
Managing both ODC and TGA licence requirements simultaneously, each with distinct documentation and reporting standards
Building robust quality systems that satisfy TGO 93 testing standards and maintain complete batch traceability
Achieving EU-GMP certification for German and UK market entry while maintaining domestic compliance
Preparing for unannounced ODC facility inspections with complete security and chain-of-custody documentation
Maximize your conference ROI by arriving prepared. Use this checklist to ensure you’re ready to make the most of every networking opportunity and business meeting.
Common questions from cannabis professionals planning to attend ACannabis Melbourne 2026.
The first day of ACannabis focuses exclusively on regulatory education and compliance workshops. Hosted by Medicinal Cannabis Industry Australia (MCIA), this intensive session provides direct access to TGA, ODC, and AHPRA representatives in a smaller forum format. Advisory Day passes consistently sell out, so early registration is essential.
ACannabis is organized by the Medicinal Cannabis Industry Australia (MCIA), the national peak body representing licensed medicinal cannabis businesses. MCIA advocates for industry interests, provides regulatory guidance, and hosts Australia’s leading industry gathering.
Yes, ACannabis welcomes international delegates. The event attracts participants from New Zealand, Asia-Pacific markets, and European companies evaluating Australian partnerships or export arrangements. International attendees particularly value the regulatory access and networking with licensed operators.
Registration dates for ACannabis 2026 have not been announced. Based on 2025 patterns, expect registration to open approximately 4-6 months before the event. Join the MCIA mailing list at acannabis.com.au for priority notification.
While both serve Australia’s medicinal cannabis industry: ACannabis (Melbourne) is hosted by MCIA with heavy regulatory focus and direct regulator participation in August. AMCA UIC (Brisbane) is hosted by Australian Medicinal Cannabis Association with broader commercial focus, typically March/April. Serious operators often attend both.
ACannabis 2026 dates are projected based on the established August timing introduced in 2025. The 7th annual event is expected to continue at Crown Promenade Melbourne, though official confirmation awaits MCIA announcement. Monitor acannabis.com.au for updates.
GrowerIQ’s seed-to-sale platform addresses the specific compliance requirements Australian operators face. Our system supports dual-licensing documentation for both ODC cultivation/manufacturing activities and TGA quality requirements in a unified platform.
Built-in TGO 93 batch record templates support testing, documentation, and traceability requirements. As Australian operators pursue EU-GMP certification for German and UK markets, GrowerIQ’s documentation supports international audit requirements. GrowerIQ’s CEO Andrew Wilson presented at ACannabis 2025, demonstrating our commitment to Australia’s medicinal cannabis industry.
See how cannabis facilities in Australia use GrowerIQ to manage ODC/TGA dual-licensing requirements and TGO 93 batch documentation.
Request Demo